Search research articles
Contact Us
Filters
Showing results (201-210 of 238) with videos related to
Page
of 24
Sort By:
Journal for Immunotherapy of Cancer
|
October 7, 2020
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8
Markus Hecht, Antoniu Oreste Gostian, Markus Eckstein, et al.
Journal for Immunotherapy of Cancer
|
August 27, 2021
<i>CTLA4</i> promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma
Niklas Klümper, Damian J Ralser, Romina Zarbl, et al.
Cell Death & Disease
|
July 31, 2024
Neutrophil extracellular traps characterize caseating granulomas
Leticija Zlatar, Jasmin Knopf, Jeeshan Singh, et al.
European Urology Oncology
|
July 14, 2026
FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting
Eva M Compérat, Arndt Hartmann, Yves Allory, et al.
British Journal of Cancer
|
July 21, 2022
pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas-proposal for a new pT3a/pT3b subclassification
Sebastian Foersch, Corinna Lang-Schwarz, Markus Eckstein, et al.
Annals of the Rheumatic Diseases
|
August 17, 2024
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Carlo Tur, Markus Eckstein, Joachim Velden, et al.
Histopathology
|
March 9, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study
Michelle R Downes, Katherine Lajkosz, Ferran Algaba, et al.
Annals of the Rheumatic Diseases
|
January 28, 2025
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Carlo Tur, Markus Eckstein, Joachim Velden, et al.
EJNMMI Research
|
March 17, 2025
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma
Michael Beck, Viktoria Blumenberg, Veit L Bücklein, et al.
European Urology Focus
|
December 18, 2025
Harnessing Artificial Intelligence for Risk Stratification and Outcome Prediction in Urologic Cancers: A Systematic Review
Navid Roessler, Marcin Miszczyk, Keiichiro Miyajima, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 238) with videos related to
Sort By:
Page
of 24
Journal for Immunotherapy of Cancer
|
October 7, 2020
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8
Markus Hecht, Antoniu Oreste Gostian, Markus Eckstein, et al.
Journal for Immunotherapy of Cancer
|
August 27, 2021
<i>CTLA4</i> promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma
Niklas Klümper, Damian J Ralser, Romina Zarbl, et al.
Cell Death & Disease
|
July 31, 2024
Neutrophil extracellular traps characterize caseating granulomas
Leticija Zlatar, Jasmin Knopf, Jeeshan Singh, et al.
European Urology Oncology
|
July 14, 2026
FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting
Eva M Compérat, Arndt Hartmann, Yves Allory, et al.
British Journal of Cancer
|
July 21, 2022
pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas-proposal for a new pT3a/pT3b subclassification
Sebastian Foersch, Corinna Lang-Schwarz, Markus Eckstein, et al.
Annals of the Rheumatic Diseases
|
August 17, 2024
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Carlo Tur, Markus Eckstein, Joachim Velden, et al.
Histopathology
|
March 9, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study
Michelle R Downes, Katherine Lajkosz, Ferran Algaba, et al.
Annals of the Rheumatic Diseases
|
January 28, 2025
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Carlo Tur, Markus Eckstein, Joachim Velden, et al.
EJNMMI Research
|
March 17, 2025
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma
Michael Beck, Viktoria Blumenberg, Veit L Bücklein, et al.
European Urology Focus
|
December 18, 2025
Harnessing Artificial Intelligence for Risk Stratification and Outcome Prediction in Urologic Cancers: A Systematic Review
Navid Roessler, Marcin Miszczyk, Keiichiro Miyajima, et al.
Page
of 24